Nitric Oxide Donors: Biochemical Pharmacology and Therapeutics

Advances in Pharmacology

Volumn 34, Issue C, 1995, Pages 361-381

  Bauer, John Anthony ^a   Booth, Brian P ^a   Fung, Ho Leung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; NITRIC OXIDE;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CARDIOVASCULAR AGENTS; HUMANS; NITRIC OXIDE;

EID: 0029442233     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)61098-4     Document Type: Article

References (96)

1. Abrams, J., Hemodynamic effects of nitroglycerin and long-acting nitrates. Am. Heart J. 110 (1985), 216–224.
2. Bassenge, E., Kukovetz, W.R., “Molsidimine,”. New Drugs Annu., Cardiovasc. Drugs., 2, 1984, Raven, New York.
3. Bassenge, E., Zanzinger, J., Effectiveness of an NO-releasing pirsidomine derviative on coronary conductance during long-term administration. J. Cardiovasc. Pharmacol. 22 (1993), S22–S26.
4. Bates, J.N., Baker, M.T., Guerra, R. Jr., Harrison, D.G., Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42 (1991), S157–S165.
5. Bauer, J.A., Fung, H.-L., Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J. Pharmacol. Exp. Ther. 256 (1991), 249–254.
6. Bauer, J.A., Fung, H.-L., Specific binding of nitroglycerin to coronary artery microsomes: Evidence of a nitrate binding protein?. FASEB J., 7, 1993, A50.
7. Bauer, J.A., Fung, H.-L., Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure. Pharm. Res. 10 (1993), 1341–1445.
8. Bauer, J.A., Fung, H.-L., Zheng, W., Kwon, Y.-W., Gopolakrishnan, M., Triggle, D.J., Continuous versus intermittent nitroglycerin administration in experimental heart failure: Vascular relaxation and radioligand binding to adrenoceptors and ion channels. J. Cardiovasc. Pharmacol. 22 (1993), 600–608.
9. Bennett, B.M., McDonald, B.J., Nigam, R., Long, P.G., Simon, W.C., Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cGMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin. Can. J. Physiol. Pharmacol. 70 (1992), 1297–1303.
10. Bennett, B.M., McDonald, B.J., Nigam, R., Simon, W.C., Biotransformation of organic nitrates and vascular muscle cell function. Trends Pharmacol. Sci. 15 (1994), 245–249.
11. Booth, B.P., Brien, J.F., Marks, G.S., Nakatsu, K., Effect of temperature on glyceryl trinitrate induced relaxation of rabbit aorta. Can. J. Physiol. Pharmacol. 71 (1993), 629–632.
12. Booth, B.P., Brien, J.F., Marks, G.S., Milne, B., Cervenko, F., Pym, J., Knight, J., Rogers, K., Salerno, T., Nakatsu, K., The effects of hypothermic and normothermic cardiopulmonary bypass on glyceryl trinitrate activity. Anesth. Analg. (Cleveland) 78 (1994), 848–856.
13. Boyer, T.D., The glutathione-S-transferase: An update. Hepatology 9 (1989), 486–496.
14. Brien, J.F., McLaughlin, B.E., Breedon, T.H., Bennett, B.M., Nakatsu, K., Marks, G.M., Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J. Pharmacol. Exp. Ther. 237 (1986), 608–614.
15. Brunton, T.L., On the use of nitrite of amyl in angina pectoris. Lancet 2 (1867), 97–98.
16. Burnett, A.L., Lowenstein, C.J., Bredt, D.S., Chang, T.S.K., Synder, S.H., Nitric oxide: A physiologic mediator of penile erection. Science 257 (1992), 401–403.
17. Chasseaud, L.F., The role of glutathione and glutathione-S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res. 29 (1990), 175–273.
18. Chiarello, M., Gold, H.K., Leinbach, R.C., Davis, M.A., Maroko, P.R., Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation 54 (1976), 766–773.
19. Chung, S.J., Fung, H.-L., Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J. Pharmacol. Exp. Ther. 253 (1990), 614–619.
20. Chung, S.J., Fung, H.-L., Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production: Probes with inhibitors and tolerance development. Biochem. Pharmacol. 45 (1993), 157–263.
21. Chung, S.J., Chong, S., Seth, P., Jung, C.Y., Fung, H.-L., Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferase. J. Pharmacol. Exp. Ther. 260 (1992), 652–659.
22. Cohn, J.N., Franciosa, J.A., Francis, G.S., Archibald, D., Tristani, F., Fletcher, R., Montero, A., Cintron, G., Clarke, J., Hager, D., Sanders, R., Cobb, F., Smith, R., Loeb, H., Settle, H., Effect of short term infusion of sodium nitroprusside on mortality in acute myocardial infarction complicated by left ventricular failure. N. Engl. J. Med. 306 (1982), 1129–1135.
23. Cohn, J.N., Effect of vasodilator therapy on mortality in chronic congestive heart failure. N. Engl. J. Med. 314 (1986), 1547–1552 and the VHeFT I Study Group.
24. Cohn, J.N., A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N. Engl. J. Med. 325 (1991), 303–310 and the VHeFT II Study Group.
25. Curling, P.E., Kaplan, J.A., Indications and uses of intravenous nitroglycerin during cardiac surgery. Angiology 312 (1982), 302–312.
26. DeMots, H., Glasser, S.P., Intermittent transdermal nitroglycerin therapy in the treatment of chonic stable angina. J. Am. Coll. Cardiol. 13 (1989), 786–793.
27. Faraci, F.M., Brian, J.E., Nitric oxide and the cerebral circulation. Stroke 25 (1994), 692–703.
28. Feelisch, M., Ostrowski, J., Noack, E., On the mechanism of NO release from syndnonimines. J. Cardiovasc. Pharmacol. 14 (1989), S13–S22.
29. Flaherty, J.T., The role of nitrates in acute myocardial infarction and post-infarction. Abrams, J., Pepine, C.J., Thadani, U., (eds.) “Medical Therapy of Ischemic Heart Disease: Nitrates, Beta Blockers and Calcium Antagonists”, 1992, Little, Brown, Boston, 309–328.
30. Flaherty, J.T., Magee, P.A., Gardner, T.L., Potter, A., MacAllister, N.P., Comparison of intravenous nitroglycerin and sodium nitroprusside for the treatment of acute hypertension developing after coronary artery bypass surgery. Circulation 65 (1981), 1072–1077.
31. Forster, S., Woditsch, I., Schroder, H., Schror, K., Reduced nitric oxide release causes nitrate tolerance in the intact coronary circulation. J. Cardiovasc. Pharmacol. 17 (1991), 867–872.
32. Fung, H.-L., Bauer, J.A., Mechanisms of nitrate tolerance. Cardiovasc. Drugs. Ther. 8 (1994), 265–275.
33. Fung, H.L., Poliszczuk, R., Nitrosothiol and nitrate therapy. Z. Kardiol. 75 (1986), 25–27.
34. Fung, H.-L., Chong, S., Kowaluk, E., Mechanisms of nitrate action and vascular tolerance. Eur. J. Pharmacol. 10 (1989), A2–A6.
35. Garg, U.C., Hassid, A., Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989), 1774–1777.
36. Gou, J.-P., Milhoan, K.A., Tuan, R.S., Lefer, A.M., Beneficial effect of SPM-5185, a cysteine-containing nitric oxide donor, in rat carotid artery intimal injury. Circ. Res. 75 (1994), 77–84.
37. Greenberg, H., Dwyer, E.M., Jameson, A.G., Pinkernell, B.M., Effects of nitroglycerin on the major determinants of myocardial oxygen consumption. An angiographic and hemodynamic assessment. Am. J. Cardiol. 36 (1975), 426–432.
38. Habig, W.H., Keen, J.H., Jakoby, W.B., Glutathione-S-transferase in the formation of cyanide from organic thiocyanates and as an organic nitrate reductase. Biochem. Biophys. Res. Commun. 64 (1975), 501–506.
39. Hampton, J.R., Harrison, A.J., Honour, A.J., Mitchell, J.R., Platelet behavior and drugs used in cardiovascular disease. Cardiovasc. Res. 1 (1967), 101–106.
40. Harrison, D.G., Bates, J.N., The nitrovasodilators. New ideas about old drugs. Circulation 87 (1993), 1461–1467.
41. Ibrahim, T.M., Unger, P.H., Sobolski, J., Depelchin, P., Jottrand, M., Degre, S., Hemodynamic effects of Sin-1 in acute left heart failure. Cardiovasc. Drugs Ther. 3 (1989), 557–561.
42. Jugdutt, B.I., Role of nitrates after acute myocardial infarction. Am. J. Med. 70 (1992), 82B–87B.
43. Jugdutt, B.I., Khan, M.I., Effect of prolonged nitrate therapy on left ventricular remodelling after canine myocardial infarction. Circulation 89 (1994), 2297–2307.
44. Kowaluk, E.A., Fung, H.-L., Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by s-nitrosothiols. J. Pharmacol. Exp. Ther. 255 (1990), 1256–1264.
45. Kowaluk, E.A., Fung, H.-L., Vascular nitric oxide-generating activities for organic nitrites and organic nitrates are distinct. J. Pharmacol. Exp. Ther. 259 (1991), 519–525.
46. Kowaluk, E.A., Seth, P., Fung, H.-L., Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther. 262 (1992), 916–922.
47. Kurz, M.A., Lamping, K.G., Bates, J.N., Eastham, C.L., Marcus, M.L., Harrison, D.G., Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ. Res. 68 (1991), 847–855.
48. Kurz, M.A., Boyer, T.D., Whalen, R., Peterson, T.E., Harrison, D.G., Nitroglycerin metabolism in vascular tissue: Role of glutathione S-transferases and relationship between NO and NO2 formation. Biochem. J. 292 (1993), 545–550.
49. Lam, J.Y.T., Chesbro, J.H., Fuster, V., Platelets, vasoconstriction, and nitroglycerin during arterial wall injury: A new antithrombotic role for an old drug. Circulation 78 (1988), 712–716.
50. Lau, D.T.W., Benet, L.Z., Effects of sulfobromophthalein and ethacrynic acid on glyceryl trinitrate relaxation. Biochem. Pharmacol. 43 (1992), 2247–2254.
51. Lefer, A.M., Siegried, M.R., Ma, X.-L., Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J. Cardiovasc. Pharmacol. 22 (1993), S27–S33.
52. Lefer, D.J., Nakanishi, K., Vinten-Johansen, J., Endothelial and myocardial cell protection by a cysteine containing nitric oxide donor after myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 22 (1993), S34–S43.
53. Leier, C.V., Bambach, D., Thompson, M.J., Cattaneo, S.M., Goldberg, R.J., Unverferth, D.V., Central and regional hemodynamic effects of intravenous isosorbide dinitrate, nitroglycerin, and nitroprusside in patients with congestive heart failure. Am. J. Cardiol. 48 (1981), 1115–1123.
54. Leier, C.V., Magorien, R.D., Desch, C.E., Thompson, M.J., Unverferth, D.V., Hydralazine and isosorbide dinitrate: Comparative central and regional hemodynamic effects when administered alone or in combination. Circulation 63 (1981), 102–109.
55. Dell'Lembo, N.J., Italia, L.J., O'Crawford, M.H., Rourke, R.A., Bedside diagnosis of systolic murmurs. N. Engl. J. Med. 318 (1988), 1572–1578.
56. Liu, Z.G., Brien, J.F., Marks, G.S., McLaughlin, B.E., Nakatsu, K., Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relxation of aorta. Eur. J. Pharmacol. 211 (1992), 129–132.
57. Liu, Z.G., Brien, J.F., Marks, G.M., McLaughlin, B.E., Nakatsu, K., Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta. J. Pharmacol. Exp. Ther. 264 (1993), 1432–1438.
58. Loscalzo, J., Antiplatelet and antithrombotic effects of organic nitrates. Am. J. Cardiol. 70 (1992), 18B–22B.
59. Mann, T., Cohn, P.F., Holman, B.L., Green, L.H., Markis, J.E., Phillips, D.A., Effect of nitroprusside on regional myocardial blood flow in coronary disease: Results in 25 patients and comparison with nitroglycerin. Circulation 57 (1978), 732–738.
60. Massie, B., Chatterjee, K., Werner, J., Greenberg, B., Hart, R., Parmley, W.W., Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am. J. Cardiol. 40 (1977), 794–801.
61. Mathews, W.R., Kerr, S.W., Biological activity of S-nitrosothiols: The role of nitric oxide. J. Pharmacol. Exp. Ther. 267 (1993), 1529–1537.
62. McDonald, B.J., Bennett, B.M., Cytochrome P-450 mediated biotransformation of organic nitrates. Can. J. Physiol. Pharmacol. 68 (1990), 1552–1557.
63. McDonald, B.J., Bennett, B.M., Biotransformation of glyceryl trinitrate by rat aortic cytochrome P-450. Biochem. Pharmacol. 45 (1993), 268–270.
64. McDonald, K.M., Francis, G.S., Matthews, J., Hunter, D., Cohn, J.N., Longterm oral nitrate therapy prevents chronic ventricular remodeling in the dog. J. Am. Coll. Cardiol. 21 (1993), 514–522.
65. Miller, R.R., Vismara, L.A., Williams, D.O., Amsterdam, E.A., Mason, D.T., Pharmacologic mechanisms of left ventricular unloading in clinical congestive heart failure. Circ. Res. 39 (1976), 127–133.
66. Moilanen, E., Vuorinen, P., Kankaanranta, H., Metsa-Ketela, T., Vapaatalo, H., Inhibition by nitric oxide donors of human polymorphonuclear leukocyte function. Br. J. Pharmacol. 109 (1993), 852–858.
67. Murrell, W., Nitroglycerin as a remedy for angina pectoris. Lancet, 1, 1879, 80.
68. Needleman, P., Hunter, F.E., The biotransformation of nitroglycerin. Biochem. Pharmacol. 14 (1965), 1225–1230.
69. Needleman, P., Johnson, E.M., Mehcanisms of tolerance development to organic nitrates. J. Pharmacol. Exp. Ther. 184 (1973), 709–715.
70. Nigam, R., Whiting, T., Bennett, B.M., Effect of glutathione S-transferase on glyceryl trinitrate activity in isolated rat aorta. Can. J. Physiol. Pharmacol. 71 (1992), 179–184.
71. Noack, E., Feelisch, M., Molecular mechanisms of nitrovasodilator bioactivation. Basic Res. Cardiol. 86:Suppl. 2 (1991), 37–50.
72. Olivari, M.T., Carlyle, P.F., Levine, B., Cohn, J.N., Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. J. Am. Coll. Cardiol. 2 (1983), 872–878.
73. Packer, M., Medina, N., Yushak, M., Lee, W.H., Hemodynamic factors limiting the response to transdermal nitroglycerin in congestive heart failure. Am. J. Cardiol. 57 (1986), 260–267.
74. Porst, H., Prostaglandin E1 and the nitric oxide donor linsidomine for erectile failure: A diagnostic comparative study of 40 patients. J. Urol. 149 (1993), 1280–1283.
75. Rajfer, J., Aronson, W.J., Bush, P.A., Dorey, F.J., Ignarro, L.J., Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic noncholinergic neurotransmission. N. Engl. J. Med. 326 (1992), 90–94.
76. Ryan, D.E., Levin, W., Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45 (1990), 153–239.
77. Schafer, A.I., Alexander, R.W., Handin, R.I., Inhibition of platelet function by organic nitrate vasodilators. Blood 55 (1980), 649–654.
78. Schroder, H., Cytochrome P-450 mediates bioactivation of organic nitrates. J. Pharmacol. Exp. Ther. 262 (1992), 298–302.
79. Schroder, H., Schror, K., Inhibitors of cytochrome P-450 reduce cGMP stimulation by glyceryl trinitrate in LLC-PK1 kidney epithelial cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 342 (1990), 616–618.
80. Sellke, F.W., Myers, P.R., Bates, J.N., Harrison, D.G., Influence of vessel size on the sensitivity of porcine microvessels to nitroglycerin. Am. J. Physiol. 258 (1990), H515–H520.
81. Sellke, F.W., Tomanek, R.J., Harrison, D.G., L-Cysteine selectivity potentiates nitroglycerin-induced dilation of small coronary microvessels. J. Pharmacol. Exp. Ther. 258 (1991), 365–369.
82. Servent, D., Delaforge, M., Ducrocq, C., Nansuy, D., Lenfant, M., Nitric oxide formation during microsomal hepatic denitration of glyceryl trinitrate: Involvement of cytochrome P-450. Biochem. Biophys. Res. Commun. 163 (1989), 1210–1216.
83. Seth, P., Fung, H.-L., Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells. Biochem. Pharmacol 46 (1993), 1481–1486.
84. Shaffer, J.E., Han, B.-J., Chern, W.H., Lee, F.W., Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine in conscious rabbits. J. Pharmacol. Exp. Ther. 260 (1992), 286–293.
85. Smith, E.R., Smiseth, O.A., Kingma, I., Mechanisms of action of nitrates. Role of changes in venous capacitance and in left ventricular diastolic pressure-volume relation. Am. J. Med. 76 (1984), 14–19.
86. Stamler, J.S., Loscalzo, J., The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J. Am. Coll. Cardiol. 18 (1991), 1529–1536.
87. Stamler, J., Cunningham, M., Loscalzo, J., Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation. Am. J. Cardiol. 62 (1988), 377–380.
88. Stamler, J.S., Vaughan, D.E., Loscalzo, J., Synergistic disaggregation of platelets by tissue type plasminogen activator, prostaglandin E1, and nitroglycerin. Circ. Res. 65 (1989), 796–804.
89. Stief, C.G., Holmquist, F., Djamilian, M., Krah, H., Andersson, K.-E., Jonas, U., Preliminary results with the nitric oxide donor linsidomine chlorhydrate in the treatment of human erectile dysfunction. J. Urol. 148 (1992), 1437–1440.
90. Thulesius, O., Cardiovascular pharmacology of molsidimine. Vanhoute, P.M., Vatner, S.F., (eds.) “Vasodilator Mechanisms”, 1984, Karger, Basel, 234–243.
91. Tsuchida, S., Maki, T., Sato, K., Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart. J. Biol. Chem. 265 (1990), 7150–7157.
92. Watkins, P.B., Role of cytochromes P-450 in drug metabolism and hepatotoxicity. Semin. Liver Dis. 10 (1990), 235–250.
93. Yeates, R.A., Schmidt, M., Leitold, M., Antagonism of glycerol trinitrate activity by an inhibitor of glutathione s-transferase. Biochem. Pharmacol. 38 (1989), 1749–1753.
94. Zhang, F., Iadecola, C., Nitroprusside improves bloodflow and reduces brain damage after focal ischemia. Neuroreport 4 (1993), 559–562.
95. Zhang, F., White, J.G., Iadecola, C., Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: Evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cerebral Blood Flow and Metab. 14 (1994), 217–226.
96. Ziche, M., Morbidelli, L., Masini, E., Granger, H., Geppetti, P., Ledda, F., Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem. Biophys. Res. Commun. 192 (1993), 1198–1203.